Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Goldman Sachs reiterates its Buy rating

06/08/2021 | 03:50pm EDT

Goldman Sachs analyst Veronika Dubajova maintains his Buy rating on the stock. The target price remains unchanged at EUR 70.


© MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
07/30ADRs End Lower; IAG, Fresenius Among Companies Actively Trading
DJ
07/30DGAP-CMS : Fresenius Medical Care AG & Co. KGaA: Release according to Article 50..
DJ
07/30FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
07/30FRESENIUS SE : Credit Suisse sticks Neutral
MD
07/30Eurostoxx 50 : European shares slip but log sixth straight month of gains
RE
07/30European ADRs Drop Nearly 0.5% as Miners, Drillers Lag
MT
07/30FRESENIUS MEDICAL CARE : Healthcare group Fresenius raises 2021 forecasts
RE
07/30FRESENIUS SE : DZ Bank keeps its Buy rating
MD
07/30SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Friday
MT
07/30DGAP-NVR : Fresenius SE & Co. KGaA: Release according to Article 41 of the WpHG ..
DJ
More news
Financials (USD)
Sales 2021 20 792 M - -
Net income 2021 1 247 M - -
Net Debt 2021 12 968 M - -
P/E ratio 2021 17,9x
Yield 2021 1,72%
Capitalization 23 130 M 23 118 M -
EV / Sales 2021 1,74x
EV / Sales 2022 1,61x
Nbr of Employees 124 995
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 78,97 $
Average target price 82,40 $
Spread / Average Target 4,34%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer